celiac disease and glp 1 GLP-1 RAs Reduce Anemia Risk in Patients with GLP-1 Agonists, Gut Microbiome Dysbiosis

Perman, Autistic disorder and gastrointestinal disease

While GLP-1 medications directly influence insulin production, these other weight loss drugs, like metformin or topiramate, work on different targets, resulting in somewhat similar appetite-suppressing effects.34 35 Hims also offers naltrexone and bupropion

Public Health 15 , 1425 (2018)

This combination enhances satiety and keeps appetite more stable throughout the day

All evaluated GLP-1 RAs led to a significant increase in nausea risk, with orforglipron showing the highest risk, followed by exenatide, tirzepatide, semaglutide, and liraglutide

plant-based protein sources